- Home
- PRLD vs MPU Comparison
PRLD vs MPU Comparison
Compare PRLD & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRLD | MPU |
|---|---|---|
| Founded | 2016 | 1989 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 65.3M |
| IPO Year | 2020 | 1998 |
Fundamental Metrics
Financial Performance| Metric | PRLD | MPU |
|---|---|---|
| Price | $2.78 | $0.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 534.1K | 161.5K |
| Earning Date | 11-12-2025 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $10,500,000.00 | ★ $31,139,100.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 250.00 | 19.98 |
| 52 Week Low | $0.61 | $0.49 |
| 52 Week High | $4.22 | $4.44 |
Technical Indicators
Market Signals| Indicator | PRLD | MPU |
|---|---|---|
| Relative Strength Index (RSI) | 62.95 | 41.77 |
| Support Level | $2.37 | $0.82 |
| Resistance Level | $3.00 | $1.13 |
| Average True Range (ATR) | 0.28 | 0.11 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 78.39 | 29.98 |
Price Performance
Historical ComparisonAbout PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About MPU Mega Matrix Corp.
Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.